Screener
Nuvation Bio NUVB Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$62.84M-6.5% | $5.4M+110% | -$36.59M+26.0% | -$55.79M-35.4% | -$59.01M+87.2% | ||
| $536K+50.6% | $536K+72.9% | $539K+146% | $534K+230% | $356K+45.9% | ||
| $10.46M-13.1% | $9.03M+15.0% | $7.99M-21.6% | $8.02M+7.3% | $12.03M+25.7% | ||
| -$42.97M+10.8% | $5.07M+112% | -$29.73M+35.8% | -$52.89M-70.1% | -$48.18M-29.1% | ||
| $254K+40.3% | $48K-33.3% | $0— | $7.75M+28,793% | $181K— | ||
| —— | -$43.64M-181% | $87.08M+68.2% | —— | $54.88M+60.1% | ||
| —— | —— | $11.2M+101% | —— | —— | ||
| $170.53M-11.8% | $44K-92.0% | $8.06M— | $501K— | $193.42M+6,939% | ||
| $133.21M-33.4% | -$38.7M-416% | $65.19M— | —— | $199.99M+88,986% | ||
| -$43.22M+10.6% | $5.02M+112% | -$29.73M+35.8% | -$60.64M-95.2% | -$48.36M-29.6% |
FAQ
- How much cash does Nuvation Bio generate?
- Nuvation Bio (NUVB) generated -$120.5M in operating cash flow over the trailing twelve months.
- What is Nuvation Bio's free cash flow?
- After $8.0M of capital expenditures, Nuvation Bio's free cash flow was -$128.6M over the trailing twelve months, up 23.7% year over year.
- Where does Nuvation Bio's cash flow data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
